ArticleFrontiers in oncology2025

Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCC.

Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.